Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,286
Award facts
- Contract value 100% obligated
- $29,286.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $29,286.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 million contract awarded in November 2025 with performance extending through December 31, 2036.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals necessary for military healthcare facilities worldwide. As one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and consistent performance fulfilling the specialized pharmaceutical requirements of the military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMQC?
SPE2DU26FEMQC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DU26FEMQC worth?
The government has obligated $29,286 on SPE2DU26FEMQC.
Is contract SPE2DU26FEMQC an order under another contract?
Yes. SPE2DU26FEMQC is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQC competed?
The extent of competition for SPE2DU26FEMQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award